HettyCarrawayMDMBA

PubMed

• 68 citations
  Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
  Judith E. Karp, B. Douglas Smith, Linda S. Resar, Jacqueline Greer, Amanda L. Blackford
  Blood. 2011-03-24
• 50 citations
  A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.
  Ivana Gojo, Jan H. Beumer, Keith W. Pratz, Michael A. McDevitt, Maria R. Baer
  Clinical Cancer Research. 2017-02-01
• 6 citations
  Inherited Thrombocytopenia Caused by Germline ANKRD26 Mutation Should Be Considered in Young Patients With Suspected Myelodysplastic Syndrome.
  Tariq Kewan, Ryan Noss, Lucy A. Godley, Heesun J. Rogers, Hetty E. Carraway
  Journal of Investigative Medicine High Impact Case Reports. 2020-07-03

Journal Articles

• "Molecular features of early onset adult myelodysplastic syndrome"  
  Hirsch CM, Przychodzen BP, Radivoyevitch T, Patel B, Thota S, Clemente MJ, Nagata Y, LaFramboise T, Carraway HE, Nazha A, Sekeres MA, Makishima H, and Maciejewski JP, Haematologica, 1/1/2017
• Selecting adjuvant endocrine therapy for breast cancer, article reviewed  
  Carraway HE, Wolff A, Oncology, 1/1/2004

Books/Book Chapters

• The Lymphoid Neoplasms 
  Chapter: "Novel Agents in Acute Lymphocytic Leukemias: A Prospective Look" 
  Page 1092 - 1122Carraway HE, Karp JEEditors: Ian Magrath.Hodder Arnold, London, EnglandEdition 3rd,2010
• Current Cancer Therapeutics 
  Chapter: "Renal and Metabolic Complications of Cancer" 
  Page 313 - 324Carraway H, Griffiths EEditors: Kirkwood JM, Lotze MT, Yasko JM.Current Medicine Group, LLC, PhiladelphiaEdition 5th,2008
• Cancer Genomics and Proteomics: Methods and Protocols. Methods in Molecular Biology 
  Chapter: "Monitoring Methylation and Gene Expression in Cancer." 
  Page 187 - 202Carraway HE, Herman JEditors: Paul B. Fisher.Humana Press, NJ2007
• Acute Myelogenous Leukemia 
  Chapter: "Modulating Gene Expression As A Therapeutic Approach In The Treatment Of Acute Myeloid Leukemia." 
  Page 275 - 291Fandy TE, Carraway HE, Gore SDEditors: Dr. Judith E. Karp.Humana Press, NJ2007
• Advanced Therapy of Breast Disease 
  Chapter: "Adjuvant Hormonal Therapy in Premenopausal Women" 
  Page 451 - 458Carraway HE, Davidson NEditors: Singletary SE, Geoffrey LR, and Hortobagyi GN.BC Decker, Ontario, Canada2004
• The Osler Medical Handbook 
  Chapter: "Anemia." 
  Page 495 - 504Carraway HE, Streiff MEditors: Cheng A. and Zaas A..Mosby, Philadelphia2003
• Join now to see all

Abstracts/Posters

• Hotspot U2AF1 Mutations Determine Missplicing Selectivity: Novel Mechanisms Altering Splicing Factors
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• RORA Is a Potential Prognostic Biomarker and Therapeutic Target for Patients with Acute Myeloid Leukemia
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate PotentialClinically Relevant Abstract
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Fatty Acid Binding Protein FABP5: A Novel Therapeutic Target in Acute Myeloid Leukemia
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Mutational Patterns and Clonal Architecture of Therapy-Related Acute Myeloid Leukemia
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Can Monosomy 7 be Targeted By Next Generation Cereblon-Modulating Agents?
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Determinants of Fitness for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• ANKRD26 Coding Variants Presenting with Giant Platelets and a Predisposition to Myeloid Neoplasia
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact and Outcomes of RAS gene Mutations in Core Binding Factor Acute Myeloid Leukemia
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving I...
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• FA Gene Carrier Status Predisposes to Myeloid Neoplasms and Bone Marrow Failure in AdultsClinically Relevant Abstract
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Therapeutic Applications of a Unique Calcium Channel Blocker to Target SF3B1 MDS
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Pharmacologic Normalization of Altered Transcriptome of SF3B1 Mutant Myeloid Neoplasia
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Molecular Characterization of Leukemia Evolving from Paroxysmal Nocturnal Hemoglobinuri
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Molecular Dissection of Del(5q): Distinction between Primary and Secondary Del(5q) and Pathogenetic Implications
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-Azacytidine
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Extended Experience with a Very Low Dose, Metronomic, Subcutaneous Decitabine Regimen Intended to Deplete DNMT1 without Cytotoxicity
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and My...
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic...
  Hetty E. Carraway, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Ordering Patterns of NGS Testing: Impact of Results on Clinical Management in Patients with Hematological Disorders.
  Patel B, Xie Y, Cook J, Carraway HE, and His, United States and Canadian Academy of Pathology (USCAP) Annual Meeting, 1/1/2018
• Join now to see all

Lectures

• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of CancerClinically Relevant Abstract 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2mutations after Intensive Chemotherapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Training Program Directors' Workshop 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Knocking Your Fellowship Interview Out of the Park: Tips to Make Sure Your Interview Day Is a Homerun 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• "Updates in Leukemia" 
  Mile High Stadium, Colorado Blood Cancer Institute, Denver, CO - 1/1/2018
• "Novel Treatments in AML, The Learning Curve for the Inpatient Hospitalist" 
  Cleveland, OH - 1/1/2018
• "Implication of Novel Induction and Targeted Strategies in AML" 
  Hollywood, FL - 1/1/2018
• "Treatment of Acute Myeloid Leukemia" 
  Cleveland Clinic, Cleveland, OH - 1/1/2018
• "Optimizing the Use of Novel Agents for the treatment of Leukemia" 
  NJ - 1/1/2018
• "Myelodysplasia" 
  Cleveland, OH - 1/25/2017
• "Novel Therapies in Adult MDS and AML" 
  John Theurer Cancer Center - 1/1/2017
• "Novel Agents in Adult AML" 
  Cleveland, OH - 1/1/2017
• "Witnessing Change After A 40 Year Drought: What An Internist Needs to Know in AML" 
  Cleveland Clinic, Cleveland, OH - 1/1/2017
• "Treatment and Management of Adults with Acute Lymphocytic Leukemia" 
  Children's Hospital of Richmond at VCU, Richmond, VA - 1/1/2017
• "Chromes, Clones and Unknowns in Myelodysplastic Syndromes" 
  Philadelphia, PA - 1/1/2017
• "What's New in Myelodysplastic Syndromes?" 
  Denver, CO - 1/1/2017
• "Novel Agents in Myelodysplastic Syndromes and Acute Myeloid Leukemia" 
  Cleveland, OH - 1/1/2017
• "Myelodysplastic Syndromes" 
  Chicago, IL - 1/1/2017
• Join now to see all

Other

• "What's New in MDS? Important Findings from ASH 2016" 
  Carraway HE, Aplastic Anemia and International MDS International Foundation (Webinar)
  1/1/2017
• "Myelodysplastic syndromes and leukemia in adults" 
  Carraway HE, Talking Health Globally, Hopkins Urban Radio Show
  http://www.hopkinsmedicine.org/diversity_cultural_competence/urban_health_radio_program/past_radio_programs.html
  Johns Hopkins University, Baltimore, MD - 1/1/2013
• "Roads Less Traveled" 
  Carraway HE, The Visionaries
  International Center for Integration of Health and Spirituality, Rockville, MD - 1/1/2001